Posts

CHMP Recommends Moderna's mCombriax Flu-COVID Vaccine for Adults 50+

on
On February 26, 2026, the EMA's CHMP recommended marketing authorization for Moderna's mCombriax (mRNA-1083), the first mRNA combination vaccine against COVID-19 and seasonal influenza for adults aged 50 and older. 2 4 5 The recommendation is based on phase III trial data from ~8,000 adults showing mCombriax elicits non-inferior or superior antibody responses compared to separate Spikevax + Fluzone HD or Fluarix vaccines. 2 3 4 If approved by the European Commission, mCombriax will be Moderna's fourth EU-marketed product; common side effects include injection site pain, fatigue, headache, and fever. 1 4 5 No search results confirm recent CHMP recommendation for a Novartis hives (urticaria) pill; available news focuses solely on Moderna's vaccine. 1 2 3 4 5 Sources: 1. https://www.fiercepharma.com/pharma/after-chmp-nod-moderna-ceo-applauds-eus-rigorous-scientific-review 2. https://www.europeanpharmaceuticalreview.com/news/271745/first-mrna-covid-19-flu-combin...

Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA's First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034

on

NIH-Funded Study Establishes New Class of Alzheimer's Biomarkers via Protein Structure Changes

on

Abbott's CardioMEMS Hero Reader Receives FDA Approval for Heart Failure Monitoring

on

Padcev-Keytruda Combination Shows Strong Positive Data in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

on

FDA’s One Trial Policy: Not a Revolution but a Potentially Risky Evolution

on

Uncertainty Looms Over Pharma's Legal Strategy as States Challenge New Vaccine Schedule

on

Boehringer Ingelheim's Hernexeos Receives Speedy FDA Approval for Lung Cancer Under CNPV Program

on

AI Tips and Prompts to Elevate Your 2026 Job Search

on

DeepHealth Achieves CE Mark for TechLive and Enables AWS Marketplace Deployment

on

Senate Hearing Criticizes FDA's Rare Disease Drug Review Process

on

Government of Canada and Partners Invest Over $41 Million in Cancer Prevention Research

on

Dexcom Appoints Google Executive Rick Osterloh to Board of Directors

on